Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
31,249,203
-
Total 13F shares
-
6,040,790
-
Share change
-
+1,288,364
-
Total reported value
-
$44,822,973
-
Put/Call ratio
-
207%
-
Price per share
-
$7.42
-
Number of holders
-
69
-
Value change
-
+$8,382,914
-
Number of buys
-
38
-
Number of sells
-
36
Institutional Holders of Actinium Pharmaceuticals, Inc. - Common Stock (ATNM) as of Q2 2023
As of 30 Jun 2023 Actinium Pharmaceuticals, Inc. - Common Stock (ATNM) had 69 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 6,040,790 shares of stock of the company.
Largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, NORTHERN TRUST CORP, DIMENSIONAL FUND ADVISORS LP, CITADEL ADVISORS LLC, Sentinus, LLC, Bank of New York Mellon Corp, and Nuveen Asset Management, LLC.
This table shows 69 institutional shareholders of the security as of 30 Jun 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.